Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT06935994 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Dysfunction Associated Steatotic Liver Disease

Interventions

DRUG: Aspirin 81 mg Enteric Coated Tab - 1 tablet
DRUG: Placebo

Sponsor

Taichung Veterans General Hospital